Health and Fitness Health and Fitness
Wed, March 6, 2013
[ Wed, Mar 06th 2013 ] - Market Wire
Alchemia Granted Key US Patent
Tue, March 5, 2013
Mon, March 4, 2013
Sun, March 3, 2013
Sat, March 2, 2013
Fri, March 1, 2013
Thu, February 28, 2013
Wed, February 27, 2013
Tue, February 26, 2013
Mon, February 25, 2013
Sun, February 24, 2013
Sat, February 23, 2013
Fri, February 22, 2013
Thu, February 21, 2013
[ Thu, Feb 21st 2013 ] - Market Wire
Inorganic Growth of Healthcare
Wed, February 20, 2013
Tue, February 19, 2013
Mon, February 18, 2013
Sun, February 17, 2013
Fri, February 15, 2013
Thu, February 14, 2013
Wed, February 13, 2013
Tue, February 12, 2013

Bronstein, Gewirtz amp;; Grossman, LLC Announces Investigation of Affymax, Inc.


//health-fitness.news-articles.net/content/2013/ .. -llc-announces-investigation-of-affymax-inc.html
Published in Health and Fitness on Monday, February 25th 2013 at 8:15 GMT by Market Wire   Print publication without navigation


Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Affymax, Inc. -- NEW YORK, Feb. 25, 2013 /PRNewswire/ --

NEW YORK, Feb. 25, 2013 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Affymax, Inc. ("Affymax" or the "Company") (Nasdaq: AFFY).  The investigation focuses on whether the Company and its executives violated federal securities laws.

On February 25, 2013, shares of Affymax plummeted over 80% in early morning trading after the company with Japanese pharmaceutical company Takeda, announced late Saturday a voluntary recall of anemia drug, Omontys, after a small percentage of patients experienced serious initial side effects, leading to a handful of patient deaths.  The F.D.A. said in a news release on Sunday that it had received 19 reports of [ anaphylaxis ], a severe allergic reaction, and that three of the patients had died, while others required prompt medical intervention or hospitalization.

If you are aware of any facts relating to this investigation, or purchased shares of Affymax, you can assist this investigation by contacting either Peretz Bronstein or Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email [ eitan@bgandg.com ]. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman , 212-697-6484
[ eitan@bgandg.com ]

SOURCE Bronstein, Gewirtz & Grossman, LLC




Publication Contributing Sources